US Stock MarketDetailed Quotes
IMMX Immix Biopharma
- 1.700
- -0.020-1.17%
Trading Nov 26 13:38 ET
46.76MMarket Cap-2023P/E (TTM)
1.780High1.680Low129.26KVolume1.710Open1.720Pre Close221.43KTurnover0.81%Turnover RatioLossP/E (Static)27.51MShares7.75052wk High2.66P/B27.14MFloat Cap1.26052wk Low--Dividend TTM15.96MShs Float8.680Historical High--Div YieldTTM5.82%Amplitude0.680Historical Low1.713Avg Price1Lot Size
Immix Biopharma Key Stats
Quarterly+Annual
YOY
| (Q3)Sep 30, 2024 | (Q2)Jun 30, 2024 | (Q1)Mar 31, 2024 | (FY)Dec 31, 2023 | (Q4)Dec 31, 2023 | (Q3)Sep 30, 2023 | (Q2)Jun 30, 2023 | (Q1)Mar 31, 2023 | (FY)Dec 31, 2022 | (Q4)Dec 31, 2022 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Operating Cash Flow (Indirect Method) | ||||||||||
| Cash flow from continuing operating activities | -30.76%-4.04M | -49.52%-5.26M | -82.93%-3.83M | -53.50%-11.37M | 31.42%-2.68M | -111.06%-3.09M | -542.58%-3.52M | -39.95%-2.09M | -366.13%-7.41M | -250.41%-3.9M |
| Net income from continuing operations | -64.58%-7.15M | -22.45%-4.41M | -113.41%-5.33M | -89.50%-15.6M | -35.67%-5.16M | -182.98%-4.34M | -130.24%-3.6M | -87.53%-2.5M | 66.25%-8.23M | 83.30%-3.8M |
| Depreciation and amortization | 1,775.89%25.91K | 4,701.38%24.3K | 4,622.77%23.85K | 156.11%5.47K | 443.46%3.08K | 143.99%1.38K | 32.11%506 | -18.55%505 | -13.49%2.14K | -8.71%566 |
| Change In working capital | 353.88%2.35M | -313.98%-1.51M | 610.34%537.1K | 746.75%1.65M | 525.41%1.42M | 467.25%518.55K | -140.61%-365.3K | 133.10%75.61K | 149.92%195.21K | 45.05%-334.75K |
| -Change in receivables | 118.03%68.54K | 285.79%96.25K | -1,162.73%-911.54K | -277.94%-893.4K | -664.45%-465.93K | -1,199.60%-380.24K | 122.64%24.95K | -100.75%-72.19K | -342.03%-236.38K | -135.73%-60.95K |
| -Change in prepaid assets | -35.90%286.41K | 114.95%198.51K | -1,009.12%-476.99K | 116.18%111.84K | 215.26%1.04M | 104.40%446.83K | -487.45%-1.33M | 87.84%-43.01K | -37.44%-691.05K | -79.77%-898.59K |
| -Change in payables and accrued expense | 342.69%2M | -292.53%-1.8M | 908.74%1.92M | 116.85%2.43M | 36.72%854.22K | 236.73%451.96K | 40.52%937.49K | 18.34%190.81K | 7,865.92%1.12M | 323.23%624.79K |
| -Change in other current assets | --0 | --0 | ---20.42K | ---- | ---- | --0 | --0 | --0 | ---- | ---- |
| -Change in other current liabilities | ---2.11K | ---2.07K | --21.31K | ---- | ---- | --0 | --0 | --0 | ---- | ---- |
| Cash from discontinued investing activities | ||||||||||
| Operating cash flow | -30.76%-4.04M | -49.52%-5.26M | -82.93%-3.83M | -53.50%-11.37M | 31.42%-2.68M | -111.06%-3.09M | -542.58%-3.52M | -39.95%-2.09M | -366.13%-7.41M | -250.41%-3.9M |
| Investing cash flow | ||||||||||
| Cash flow from continuing investing activities | -597.84%-271.54K | -97.07K | -301.91K | -52.09K | -13.18K | -38.91K | 0 | 0 | 0 | 0 |
| Net PPE purchase and sale | -597.84%-271.54K | ---97.07K | ---301.91K | ---52.09K | ---13.18K | ---38.91K | --0 | --0 | --0 | --0 |
| Cash from discontinued investing activities | ||||||||||
| Investing cash flow | -597.84%-271.54K | ---97.07K | ---301.91K | ---52.09K | ---13.18K | ---38.91K | --0 | --0 | --0 | --0 |
| Financing cash flow | ||||||||||
| Cash flow from continuing financing activities | 0 | 0 | 13,311.62%15.95M | 378.44%15.46M | 38.28%586.69K | 10.07M | 4,527.64%4.69M | -95.92%118.92K | -82.85%3.23M | -97.73%424.28K |
| Net issuance payments of debt | ---- | ---- | ---- | --0 | ---- | ---- | ---- | ---- | -125.00%-50K | --0 |
| Net common stock issuance | --0 | --0 | 15,245.16%15.95M | 377.24%15.7M | 76.12%759.07K | --9.95M | 8,824.47%4.88M | -96.43%103.92K | -82.36%3.29M | -97.69%431K |
| Proceeds from stock option exercised by employees | --0 | --0 | --2.49K | --2.62K | --2.62K | --0 | --0 | --0 | --0 | ---- |
| Net other financing activities | ---- | ---- | ---- | -3,389.23%-234.62K | ---175K | --116.2K | ---190.82K | --15K | ---6.72K | ---- |
| Cash from discontinued financing activities | ||||||||||
| Financing cash flow | --0 | --0 | 13,311.62%15.95M | 378.44%15.46M | 38.28%586.69K | --10.07M | 4,527.64%4.69M | -95.92%118.92K | -82.85%3.23M | -97.73%424.28K |
| Net cash flow | ||||||||||
| Beginning cash position | 89.47%23.98M | 155.77%29.32M | 30.31%17.51M | -23.85%13.44M | 15.76%19.58M | -31.24%12.65M | -39.86%11.46M | -23.85%13.44M | 4,411.66%17.64M | 44,423.02%16.92M |
| Current changes in cash | -162.06%-4.31M | -555.07%-5.35M | 699.05%11.82M | 196.74%4.04M | 39.54%-2.1M | 574.58%6.94M | 280.13%1.18M | -239.05%-1.97M | -124.20%-4.18M | -119.76%-3.48M |
| Effect of exchange rate changes | 295.07%22.96K | -36.97%8.91K | -1,744.48%-10.37K | 204.97%33.09K | 20,028.66%31.29K | 49.57%-11.77K | 366.53%14.14K | 79.35%-562 | -480.23%-31.52K | -125.28%-157 |
| End cash Position | 0.55%19.69M | 89.47%23.98M | 155.77%29.32M | 30.31%17.51M | 30.31%17.51M | 15.76%19.58M | -31.24%12.65M | -39.86%11.46M | -23.85%13.44M | -23.85%13.44M |
| Free cash flow | -37.82%-4.31M | -52.28%-5.35M | -97.36%-4.13M | -54.20%-11.42M | 31.08%-2.69M | -113.72%-3.13M | -542.58%-3.52M | -39.95%-2.09M | -365.90%-7.41M | -250.41%-3.9M |
| Currency Unit | USD | USD | USD | USD | USD | USD | USD | USD | USD | USD |
| Audit Opinions | -- | -- | -- | Unqualified Opinion | -- | -- | -- | -- | Unqualified Opinion | -- |
Analysis
Price Target
No Data
Heat List
US
Overall
Symbol
Latest Price
% Chg
No Data